Recalibrating the Risks and Benefits of Lithium Therapy

Overview

Journal Br J Psychiatry

Publisher Cambridge University Press

Specialty Psychiatry

Date 2017 Jul 5

PMID 28673941

Citations 6

Authors

Michael Berk

Stephanie Cowdery

Lana Williams

Gin S Malhi

Affiliations

Soon will be listed here.

Abstract

Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this , a surprising reduction in the risk of cancer.

Citing Articles

Facts and myths about the use of lithium for bipolar disorder in routine clinical practice: an expert consensus paper.

Fiorillo A, Sampogna G, Albert U, Maina G, Perugi G, Pompili M Ann Gen Psychiatry. 2023; 22(1):50.

PMID: 38057894 PMC: 10702081. DOI: 10.1186/s12991-023-00481-y.

A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology.

Drozd M, Capovilla M, Previdere C, Grossi M, Askenazy F, Bardoni B Front Genet. 2022; 12:792218.

PMID: 34976023 PMC: 8719199. DOI: 10.3389/fgene.2021.792218.

Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges.

De-Paula V, Forlenza O Naunyn Schmiedebergs Arch Pharmacol. 2021; 395(1):105-113.

PMID: 34751792 DOI: 10.1007/s00210-021-02171-6.

Trace Elements in Human Nutrition (II) - An Update.

Mehri A Int J Prev Med. 2020; 11:2.

PMID: 32042399 PMC: 6993532. DOI: 10.4103/ijpvm.IJPVM_48_19.

Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.

Davis J, Desmond M, Berk M BMC Nephrol. 2018; 19(1):305.

PMID: 30390660 PMC: 6215627. DOI: 10.1186/s12882-018-1101-4.